More than 10,000 pharmacy contractors those have declared their March FP34C submission figures through the Manage Your Service (MYS) portal by 5 April will
receive earlier advance payments on Monday 11 April, the NHS Business Services Authority (NHSBSA) announced.
Around 10,700 pharmacy contractors have made their submissions through MYS portal. They will receive their advance payments some 20 days earlier than the normal
payment timetable.
However, due to late submission (after April 5), over 500 contractors will not receive any earlier advance payments in April. These contractors will receive their advance payments on 1 May, in accordance with the normal payment timetable.
From this month, MYS is the only route available to contractors for all monthly FP34C submissions.
The Pharmaceutical Services Negotiating Committee (PSNC) reminded contractors that from this month (for prescriptions dispensed in March), the NHSBSA may apply an administrative deduction of £25 if a prescription bundle is submitted late.
Prime minister Boris Johnson received his Covid-19 booster shot on Thursday (December 2) and urged others to follow suit to help the country fend off the Omicron variant of coronavirus.
Wearing a mask, Johnson briefly chatted to staff and others queuing for their shots at the vaccination centre in central London, asking them if they were there to receive a booster dose and thanking them for attending.
Johnson, who said it could "have gone either way" when he was treated in hospital for Covid last year, was later filmed rolling up his shirt sleeve and receiving his shot.
"Fantastic. Thank you so much," he said to the nurse, before receiving a badge that said "I've boosted my immunity".
More than 6,000 pharmacy contractors who declared their October 2021 FP34C submission figures by November 5, will have received earlier advance payments on November 11.
The contractors had submitted their claims through the Manage Your Service (MYS) portal.
All contractors who received payments under the system would have got a letter from the NHS Business Services Authority (NHSBSA) regarding these payments,PSNC stated.
Approximate 3,000 contractors submitted claims after November 5, and will receive payments as per the normal payment timetable on December 1, it said.
The negotiator encouraged contractors to benefit from earlier advance payments by submitting their monthly declaration through the MYS portal by the 5th of the month.
Pharmacy owners can proceed with vaccinating patients who have already scheduled their flu vaccination appointments for September, NHS England has said.
However, as announced earlier, the official rollout of the vaccination service will commence from October.
Pharmacies will receive compensation for conducting appointments in the upcoming month, NHSE stated in a letter addressed to systems, community pharmacies, and
general practices.
"Payment for vaccinations will ordinarily only be made following the service commencement date. However, we understand that some firm commitments and appointments
have already been made, so where this is the case and the patient wishes to receive flu vaccination in September, NHS England will permit payment claims to be
submitted," NHSE said.
Care home residents and staff will be eligible for the vaccine starting Oct. 2, while all other patients will commence receiving their vaccinations on Oct 7.
This news is a significant relief for pharmacy owners, as they won't have to reschedule appointments due to NHSE's one-month service delay.
The National Health Service will begin its autumn Covid vaccine program next week, a month earlier than planned in response to the spread of a new variant
dubbed Pirola. Covid vaccines will be administered to care home residents and housebound individuals from Monday onwards, while over-65s and other vulnerable
groups will receive their appointments the week after.
On Aug. 30, NHS England shifted the autumn vaccination drive to start on September 11 in response to the new Covid-19 variant, BA.2.86, detected on August 18.
The primary groups can book through a national system upon receiving an invitation from the NHS. Some people may get an earlier call from their GP, and a few have
already scheduled Covid vaccinations alongside their flu jabs.
The NHS will begin inviting other eligible groups from Sept. 18. However, it is important to note that not everyone will receive a call at the same time. These
groups will include individuals aged 65 and over, those aged six months to 64 years in a clinical risk category, frontline health and social care workers, and
individuals aged 12 to 64 who are carers or household contacts of those with immunosuppression.
The Pharmaceutical Services Negotiating Committee (PSNC) has advised the pharmacy contractors to check that their PMR systems supports correct and complete
SSP endorsements.
Several tips has been shared by the PSNC with pharmacy contractors after NHSBSA received several electronic EPS SSP claims which did not meet the requirements for
a valid SSP between 1 April 2022 and 31 May 2022.
PSNC has been working with NHS Business Services Authority (NHSBSA) to understand whether claims for HRT SSPs are being submitted correctly and in accordance with
the specific supporting guidance for each SSP.
"For any invalid SSP claims, contractors will continue to receive the usual dispensing fee but will not receive any SSP fee (£5.35). Reimbursement for invalid SSP
claims will also be in accordance with the prescribed product rather than the alternative product or quantity supplied in accordance with an SSP," said PSNC.
Community pharmacy contractors eligible under the revised Pharmacy Access Scheme (PhAS) will receive their first of the new monthly payments with the January reconciliation payment due on April 1, 2022.
Details of the revised version of the PhAS that commenced from January 1, was published in August 2021, with contractors receiving letters from the NHS Business
Services Authority (NHSBSA) indicating their eligibility in the Autumn, PSNC said in an update.
Payments under the scheme are dependent on registration on NHSBSA's Manage Your Service (MYS) portal to provide the Community Pharmacist Consultation Service(CPCS).
Meanwhile, the review application window is now open for contractors, which would enable the NHS England and NHS Improvement (NHSE&I) to correct inaccuracies related to a pharmacy's distance criteria/calculation.
The voter turnout in England for the Royal Pharmaceutical Society's English Pharmacy Board election dropped to 7.9 per cent this year.
Out of a total of 19,512 eligible individuals, only 1,534 decided to vote.
The RPS English Board received ten nominations for five vacancies this year; therefore an election was conducted. One nomination was received for the three
vacancies on the Welsh Pharmacy Board. Three nominations were received for the three vacancies on the Scottish Pharmacy Board. Therefore, no election was
conducted in pharmacy boards in Wales or Scotland.
RPS president Claire Anderson said: "It's disappointing that the voter turnout in England has dropped to 7.9 from 11.8 per cent in 2021. We have now appointed
an independent review of how RPS members, elected members and stakeholders can feel more engaged and empowered to influence RPS decisions, and eagerly await
its recommendations."
The Society appointed communications agency Luther Pendragon to lead a review into how it can develop and strengthen member participation.
More than 9,300 pharmacy contractors would benefit from earlier advance payment in February, Pharmaceutical Services Negotiating Committee (PSNC) said in an update.
Contractors who declared their January 2022 FP34C submission figures through the Manage Your Service (MYS) portal by February 5 will receive earlier advance payments
by today (February 10).
The statistics indicates nearly 2,000 contractors will not receive any earlier advance payment this month, either because their January declarations were submitted late or they used the paper FP34C submission document to make their declaration, PSNC said.
These contractors will receive their advance payments in accordance with the normal payment timetable i.e. on March 1.
The negotiator reminded contractors that from April 2022 MYS will be the only process to make monthly submissions.
The 1000th Building the Community-Pharmacy Partnership (BCPP) programme in Centred Soul, Newry received funding from the Department of Health in Northern
Ireland to improve the health and wellbeing of women in the local community.
BCPP programme is led by Community Development and Health Network (CDHN) in Northern Ireland and is funded by the Department of Health.
It supports communities and community pharmacists to address locally defined needs so that people make connections, listen to and understand each other better and
work together to address the social determinants of health and health inequalities
Department of Health's Chief Pharmaceutical Officer, Cathy Harrison said: "I am delighted to mark the 1000th project to receive funding to improve health inequalities
in the Newry area.
"Since 2001 we have invested over £7 million in local community groups and pharmacy partnerships across Northern Ireland, to work together on a specific, local health
need.
"The Centred Soul project is a great example of how BCPP Programme contributes to tackling inequality and improving community health and wellbeing locally.
Nine in ten people surveyed by Ipsos on behalf on NHS positively rated the advice they received from their local pharmacies.
The results from Ipsos found that the vast majority of patients (91%) who had used a community pharmacy in the previous year for advice about medicines, a health
problem or injury, or what health service they should use said they received good advice.
The research comes as more than 11,000 pharmacies in England can now access training to spot signs of cancer as part of a new drive to catch tumours earlier when
they are easier to treat.
Thorrun Govind, Chair of the Royal Pharmaceutical Society English Pharmacy Board, said: "Community pharmacists are working exceptionally hard to make sure that the
public gets the right advice at the right time. This new data shows the public appreciate both the accessibility and quality of advice they receive from community
pharmacists.
"I am delighted that the Royal Pharmaceutical Society is working with the NHS to deliver professional development for community pharmacists to further enhance their
clinical consultation skills.
Great news for multiple sclerosis patients! The NHS has introduced a new 10-minute injection that can slow the progression of disability while reducing
hospital treatment time by over 90 per cent.
Currently, MS patients in England receive ocrelizumab (Ocrevus), manufactured by Roche, through twice-yearly intravenous (IV) infusions that can last up to
four hours.
Now, around 9,000 NHS patients in England will be able to receive the drug via a quick 'under-the-skin' twice-yearly injection. It takes just ten minutes,
enabling patients to spend less time in the hospital receiving treatment.
This roll-out follows approval from the Medicines and Healthcare products Regulatory Agency (MHRA), making the NHS one of the first healthcare systems
worldwide to offer this new MS injection. Drug stocks are expected to be available in the coming weeks.
If there is a difference in numbers on documents and accounts, you need to review and check for discrepancies in the revenue cycle management, especially the accounts receivable. Avoid the following four major pitfalls and generate revenue consistently.
Community pharmacy contractors will start receiving materials for the winter vaccines campaign via Royal Mail from today (November 8).
It is the second mandated health campaign for 2021/22 in which contractors must participate as part of their NHS contractual requirements, after the NHS England and NHS Improvement and Pharmaceutical Services Negotiating Committee (PSNC) reached an agreement.
The campaign pack, to be arrived in pharmacies, includes a briefing sheet; four A4 posters; one Q&A leaflet; and one A6 shelf wobbler along with social media and digital resources.
PSNC has also reminded contractors to have "an action plan" promote Covid-19 vaccinations, particularly in Black, Asian and minority ethnic and low uptake communities.
Nearly 9,000 pharmacy contractors benefitted from earlier advance payment in January, Pharmaceutical Services Negotiating Committee (PSNC) said in an update.
Contractors who declared their December FP34C submission figures (for the dispensed prescriptions) through the Manage Your Service (MYS) portal by January 6, would have received earlier advance payments on January 12.
Meanwhile, all contractors who made submissions after January 6 or used the FP34C paper document, will receive payments as per the normal payment schedule i.e. on
February 1, 2022.
PSNC encouraged contractors to submit their monthly declaration through the MYS portal by the 5th of the month to avail early payments.
British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral therapy for the treatment of
inflammatory and respiratory diseases using its NRF2 Activator programme.
The Manchester-based company said on Monday (November 28) it would receive pre-clinical milestone payments worth up to $16 million ahead of the first clinical trial,
including $2 million upfront.
In addition, C4XD said it would receive a further potential $385.8 million in clinical development and commercial milestones and tiered mid-single digit royalties
upon commercialisation of any treatment.
Boots pharmacists will receive a pay rise of 4.5 per cent as the pharmacy multiple and PDA Union jointly announce this year's pay settlement.
Following discussions between Boots management services and the PDA Union negotiators, the agreement was reached in relation to this year's pay claim, effective
from 1 November 2022.
The union also announced that those who have already had a pay increase on or since 1 August 2022, where that increase has been less than 4.5 per cent, a 'top up'
increase will be provided, from 1 November 2022, to ensure that all eligible members of the bargaining unit receive a pay increment of not less than 4.5 per cent in
2022.
Boots and the PDA Union have agreed an increase to the pay of those above the maximum market range by 4 per cent with an additional 0.5 per cent non-consolidated
payment.
Community pharmacies in England will continue to receive the free protective equipment (PPE) as the Government's scheme has been extended for another year until
March 2024.
The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social
care staff according to demand until the end of March 2024, or when stocks run out.
Last year, DHSC implemented a new and improved portal platform for eligible providers to access free COVID-19 related PPE supplies.
The Pharmaceutical Services Negotiating Commitee (PSNC) said: "Community pharmacy teams can continue to order PPE from the NHS PPE portal for free for as long as
stock is available."
Thousands of people in Britain infected with HIV and hepatitis C through contaminated blood transfusions will receive a compensation payment decades after
the scandal, the government announced on Wednesday (August 17).
The payment of £100,000 ($121,000) to each victim is an interim one after Brian Langstaff, the chairman of a public inquiry into the long-running scandal, last
month recommended making immediate payouts before waiting for an ongoing inquiry to conclude.
The former High Court judge said that the "moral case for compensation is beyond doubt".
The government said the tax-free payments, to survivors of the scandal and bereaved partners of the thousands estimated to have died from the contaminated blood,
would be made by the end of October.
Thousands of people with haemophilia contracted hepatitis C and HIV after receiving blood transfusions, mainly from the United States, through the NHS in the 1970s,
1980s and 1990s.
Due to a shortage of blood products in Britain, the NHS bought much of its stock from US suppliers whose donors, including prisoners and other groups at high risk of
infection, had been paid for their blood.
Essential Pharma, an international speciality pharma group, has procured an establishment and manufacturing licences in Switzerland and Malta.
Following a successful inspection by Swissmedic, the company has been granted an establishment licence in Switzerland, which will allow the company to significantly
enhance its supply chain efficiency for a wide range of important medicinal products. It will apply to transactions for both finished and unfinished pharmaceuticals,
allowing importing, exporting, wholesaling and trading abroad.
Essential Pharma has also received a manufacturing and importation authorisation (MIA) in Malta, following a successful Good Manufacturing Practice (GMP) inspection
by the Malta Medicines Authority.
The MIA will allow the company to import medicinal products into the European Union where manufacturing has taken place in a third country. This will allow greater
flexibility in how the business manages the flow of medicines across its territories.
These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner. They
will also provide new strategic opportunities for the company and will play a fundamental role in driving value creation through functional improvements to scale
and productivity.